Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2007 by University of Southern California.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Southern California
ClinicalTrials.gov Identifier:
NCT00520416
First received: August 22, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted
  Purpose

Endovascular repair of infrarenal abdominal aortic aneurysms (AAA) requires a contrast agent to identify the vascular anatomy and placement of the stent graft. Iodine contrast has traditionally been used, but has the potential to harm the kidneys. Another contrast agent is carbon dioxide gas. It has been proven safe to use, but the quality of the images it creates needs to be compared to iodine contrast. Patients in this study undergo the endovascular AAA repair as they normally, with the iodine contrast. At the end of surgery carbon dioxide gas contrast is given as an extra step. The images will be later evaluated.


Condition Intervention
Carbon Dioxide
Endovascular Abdominal Aortic Aneurym Repair
Prospective
Angiogram
Procedure: Carbon dioxide angiogram

Study Type: Observational
Study Design: Observational Model: Defined Population
Primary Purpose: Screening
Time Perspective: Longitudinal

Resource links provided by NLM:


Further study details as provided by University of Southern California:

Study Start Date: October 2006
Estimated Study Completion Date: August 2008
Groups/Cohorts Assigned Interventions
Case: 1
There is no control or experimental group. The same patients undergoing endovascular AAA repair with serve as their own control
Procedure: Carbon dioxide angiogram
see description of procedure

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Infrarenal abdominal aortic aneurysm amendable to endovascular repair

Exclusion Criteria:

  • renal failure or contraindication to receiving iodine contrast.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00520416

Contacts
Contact: Wesley Lew, MD 323-442-5988 wlew@surgery.usc.edu

Locations
United States, California
USC University Hospital Recruiting
Los Angeles, California, United States, 90033
Sponsors and Collaborators
University of Southern California
Investigators
Principal Investigator: Fred A Weaver, MD University of Southern California
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00520416     History of Changes
Other Study ID Numbers: HS-06-00263
Study First Received: August 22, 2007
Last Updated: August 22, 2007
Health Authority: United States: Institutional Review Board

ClinicalTrials.gov processed this record on September 16, 2014